Successful partnership: Sciensano, Rwanda FDA & Enabel

The Team Europe MAV+ initiative aims to support the African Union ambitions to establish resilient local production of vaccines and health products, and strengthen the pharmaceutical ecosystem across the continent.
Through a partnership with Sciensano, the Rwanda Food and Drugs Authority benefits from the expertise of European regulatory agencies as well as staff training. Additionally, Enabel and MAV+ teams collaborate with the University of Rwanda, ULB and the Institute of Tropical Medicine to enhance research capacities, research ethics and provide lab equipment.